| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
| NPHP3-ACAD11 |
|
NPHP3-ACAD11 readthrough (NMD candidate)
|
|
|
0.663 |
0.577 |
| LINC01122 |
|
long intergenic non-protein coding RNA 1122
|
|
|
0.821 |
0.269 |
| MEF2C-AS1 |
|
MEF2C antisense RNA 1
|
|
|
0.861 |
0.154 |
| TSPOAP1-AS1 |
|
TSPOAP1, SUPT4H1 and RNF43 antisense RNA 1
|
|
|
0.792 |
0.346 |
| CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
| INHCAP |
|
inhibitor of carbonic anhydrase pseudogene
|
|
|
0.890 |
0.231 |
| SOCAR |
|
serous ovarian cancer associated RNA
|
|
|
0.821 |
0.231 |
| EHMT2-AS1 |
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
|
0.780 |
0.462 |
| STARD4-AS1 |
|
STARD4 antisense RNA 1
|
|
|
0.890 |
0.115 |
| LINC01221 |
|
long intergenic non-protein coding RNA 1221
|
|
|
1.000 |
0.038 |
| CSRP3-AS1 |
|
CSRP3 and E2F8 antisense RNA 1
|
|
|
|
|
| RAB11B-AS1 |
|
RAB11B antisense RNA 1
|
|
|
0.890 |
0.038 |
| HORMAD2-AS1 |
|
HORMAD2 and MTMR3 antisense RNA 1
|
|
|
0.839 |
0.308 |
| TMEM72-AS1 |
|
TMEM72 antisense RNA 1
|
|
|
|
|
| PSMA3-AS1 |
|
PSMA3 antisense RNA 1
|
|
|
0.931 |
0.154 |
| LINC01137 |
|
long intergenic non-protein coding RNA 1137
|
|
|
|
|
| NEDD8-MDP1 |
|
NEDD8-MDP1 readthrough
|
|
2.5E-03 |
|
|
| RPL6P9 |
|
ribosomal protein L6 pseudogene 9
|
|
|
|
|
| SYCE3 |
A1L190
|
synaptonemal complex central element protein 3
|
|
0.60 |
|
|
| UNC119B |
A6NIH7
|
unc-119 lipid binding chaperone B
|
Receptor
|
0.78 |
|
|
| SLC22A20P |
A6NK97
|
solute carrier family 22 member 20, pseudogene
|
|
|
|
|
| C11orf58 |
O00193
|
chromosome 11 open reading frame 58
|
|
0.17 |
0.861 |
0.154 |